financetom
Market
financetom
/
Market
/
Torrent Pharma shares fall 8% after reporting net loss of Rs 152 crore for Q4
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Torrent Pharma shares fall 8% after reporting net loss of Rs 152 crore for Q4
May 21, 2019 2:27 AM

Torrent Pharmaceuticals shares slipped nearly 8 percent on Tuesday after it reported a consolidated net loss of Rs 152 crore in March-quarter as compared to a consolidated profit of Rs 228 crore in the year-ago quarter.

Share Market Live

NSE

The stock fell as much as 7.8 percent to hit the day's low of Rs 1,525 per share on the BSE. At 10:35 am, the stock was trading 4.3 percent lower at Rs 1,585 as compared to a 0.3 percent (123 points) rise in the BSE Sensex at 39,476.

Net loss of Rs 152 crore for the fourth quarter was on account of the one-time loss of Rs 357 crore. The consolidated revenue from operations stood at Rs 1,856 crore for Q4. It was Rs 1,708 crore for the same period a year ago.

The company’s consolidated total income rose 7 percent to Rs 1,873 crore from Rs 1,750 crore (YoY). EBITDA (earnings before interest, tax, depreciation, and amortization) margin was down 187 basis points (bps) at 25.5 percent on a sequential basis.

One basis point is a hundredth of a percentage point.

For FY19, the company posted a net profit of Rs 436 crore as against Rs 678 crore for the previous fiscal year. The company's board has declared a final dividend of Rs 4 per equity share, Torrent Pharmaceuticals said.

Also, track all live market action on CNBC-TV18 Market Blog

Disclaimer: CNBCTV18.com advises users to check with certified experts before taking any investment decisions

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Traders Weigh Conflicting Signals on US-Iran Talks, Driving Premarket Losses for US Equity Futures
Traders Weigh Conflicting Signals on US-Iran Talks, Driving Premarket Losses for US Equity Futures
Mar 24, 2026
08:19 AM EDT, 03/24/2026 (MT Newswires) -- US equity futures were lower pre-bell Tuesday as traders stayed on the sidelines amid the latest developments in the US-Iran conflict. Dow Jones Industrial Average futures were down 0.5%, S&P 500 futures were 0.4% lower, and Nasdaq futures were also down 0.4%. President Donald Trump said Monday in a Truth Social post that...
Sector Update: Tech
Sector Update: Tech
Mar 24, 2026
08:52 AM EDT, 03/24/2026 (MT Newswires) -- Technology stocks were mixed premarket Tuesday, with the State Street Technology Select Sector SPDR Fund (XLK) slightly lower and the State Street SPDR S&P Semiconductor ETF (XSD) up 1.1%. Concentrix ( CNXC ) stock was down more than 10% after the company reported a decline in fiscal Q1 adjusted earnings which, along with...
Sector Update: Tech Stocks Mixed Premarket Tuesday
Sector Update: Tech Stocks Mixed Premarket Tuesday
Mar 24, 2026
09:09 AM EDT, 03/24/2026 (MT Newswires) -- Technology stocks were mixed premarket Tuesday, with the State Street Technology Select Sector SPDR Fund (XLK) 0.5% lower and the State Street SPDR S&P Semiconductor ETF ( XSD ) up 0.3%. Concentrix ( CNXC ) stock was down more than 11% after the company reported a decline in fiscal Q1 adjusted earnings which,...
Sector Update: Health Care
Sector Update: Health Care
Mar 24, 2026
08:56 AM EDT, 03/24/2026 (MT Newswires) -- Health care stocks were mixed pre-bell Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.2% and the iShares Biotechnology ETF (IBB) slightly higher. Amylyx Pharmaceuticals ( AMLX ) shares were up more than 4% after the company said it has completed patient enrollment for the phase 3 trial...
Copyright 2023-2026 - www.financetom.com All Rights Reserved